86 related articles for article (PubMed ID: 5454432)
1. [Experimental study of disopyramide as an anti-arrhythmic agent].
Kabela E; Pastelín G; Scheffler L; Sánchez-Pèrez S; Mendez R
Minerva Med; 1970 Sep; 61(71 Suppl):3694-706. PubMed ID: 5454432
[No Abstract] [Full Text] [Related]
2. [Pharmacology and toxicology of disopyramide].
Jequier R; Deraedt R; Plongeron R; Vannier B
Minerva Med; 1970 Sep; 61(71 Suppl):3689-93. PubMed ID: 5454431
[No Abstract] [Full Text] [Related]
3. Comparative effect of imolamine, lidocaine and disopyramide on experimental rhythm disorders and auriculoventricular conduction.
Junien JL; Lakatos CR; Tine J
Arzneimittelforschung; 1974 Nov; 24(11):1743-7. PubMed ID: 4141258
[No Abstract] [Full Text] [Related]
4. Clinical pharmacology of the antiarrhythmic agent disopyramide phosphate (Norpace).
Befeler B; Lazzara R
Heart Lung; 1980; 9(3):475-82. PubMed ID: 6901520
[No Abstract] [Full Text] [Related]
5. [Anti-arrhythmic activity of 17-monochloroacetylajmaline as compared with that of 17-21-dichloroacetylajmaline. Experimental and clinical study].
Capra C; Pretolani E
Minerva Cardioangiol; 1973 Dec; 21(12):789-820. PubMed ID: 4780270
[No Abstract] [Full Text] [Related]
6. [Electrophysiological interrelations of disopyramide with atropine].
González Maqueda I; García Fernández F; Martin Jadraque L; López Sendon JL; Coma Canella I
Rev Esp Cardiol; 1979; 32(2):127-31. PubMed ID: 472418
[No Abstract] [Full Text] [Related]
7. [Effects of disopyramide on the atrio-ventricular conduction in man. Preliminary results in 13 cases studied by means of recording bundle of His].
Lotto A; Graziina A; Rota M; Cavallaro GF; Greco EM
Boll Soc Ital Cardiol; 1973; 18(10):934-6. PubMed ID: 4807027
[No Abstract] [Full Text] [Related]
8. The actions of verapamil on experimental arrhythmias.
Rodrigues-Pereira E; Viana AP
Arzneimittelforschung; 1968 Feb; 18(2):175-9. PubMed ID: 5695375
[No Abstract] [Full Text] [Related]
9. [Observations on experimental acute quinidine poisoning].
De Micheli A; Medrano GA; Villarreal A; Sodi Pallares D
Arch Inst Cardiol Mex; 1972; 42(4):580-8. PubMed ID: 5073705
[No Abstract] [Full Text] [Related]
10. [On some nerve mechanisms in the origin of and effect on arrhythmias].
Jurkovic V; Vokrouhlický L
Cas Lek Cesk; 1969; 108(13):381-8. PubMed ID: 5780132
[No Abstract] [Full Text] [Related]
11. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
Bergey JL; Sulkowski T; Much DR; Wendt RL
Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506
[TBL] [Abstract][Full Text] [Related]
12. The effect of disopyramide on in vivo measurement of monophasic action potential in canine heart muscle.
Edwards IR; Martin JF; Ward JW
J Int Med Res; 1976; 4(1 Suppl):26-30. PubMed ID: 1026525
[No Abstract] [Full Text] [Related]
13. [Blocking of the adrenergic receptors in the vessels and in the heart].
Méndez R
Arch Inst Cardiol Mex; 1967; 37(6):783-809. PubMed ID: 4868243
[No Abstract] [Full Text] [Related]
14. [Comparison of the dromotropic effects of disopyramide, dihydroquinidine and procainamide].
Duchene-Marullaz P; Schaff G; Lavarenne J; Lautier F; Lapalus P
Therapie; 1971; 26(1):89-95. PubMed ID: 5554771
[No Abstract] [Full Text] [Related]
15. [Studies on the effect of peruvoside on heart function in animal experiments].
Schorscher E; Sommer S; Wild AJ; Block A
Arzneimittelforschung; 1968 Dec; 18(12):1582-90. PubMed ID: 5756257
[No Abstract] [Full Text] [Related]
16. Experimental cardiac arrhythmias in the evaluation of anti-arrhythmic drugs.
Allen EKUE JM; Pantridge JF; Shanks RG; Zaidi SA
Br J Anaesth; 1971 Jul; 43(7):720-1. PubMed ID: 5564246
[No Abstract] [Full Text] [Related]
17. [Calcium-antagonist-type cardiac effects of nifedipine in vitro and in vivo. Comparative experimental study].
Cosín J; Gimeno JV; Martín G; Ramírez A; Ferrer J; Báguena J
Rev Esp Cardiol; 1982; 35(5 Suppl 2):II115-22. PubMed ID: 7170402
[No Abstract] [Full Text] [Related]
18. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
Bianchi C; Sanna GP; Turba C
Arzneimittelforschung; 1968 Jul; 18(7):845-50. PubMed ID: 5755831
[No Abstract] [Full Text] [Related]
19. Adverse effects of disopyramide (Norpace): toxic interactions with other antiarrhythmic agents.
Ellrodt G; Singh BN
Heart Lung; 1980; 9(3):469-74. PubMed ID: 6901519
[No Abstract] [Full Text] [Related]
20. [Influencing of AV-conduction by sparteine in animal experiments].
Weidner A; von Philipsborn G
Med Klin; 1970 Nov; 65(47):2063-6. PubMed ID: 5521844
[No Abstract] [Full Text] [Related]
[Next] [New Search]
